title: Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer.
abstract: A patient with extensive and painful chest wall involvement from a metastatic borderline cancer of the ovary was treated with a carboplatin plus paclitaxel chemotherapy regimen. She achieved a rather dramatic improvement of pain control, a significant biochemical response with 75% reduction of the CA-125 antigen level, but only limited radiographic tumor regression. This experience emphasizes the potential clinical utility of platinum-based cytotoxic chemotherapy in the setting of symptomatic advanced borderline ovarian cancer.
authors.affiliation: Hematology/Oncology Division, Southern California Kaiser Permanente Medical Group, San Diego, Calif., USA.
authors.forename: Jian
authors.initials: J
authors.lastname: Chen
authors.forename: Maurie
authors.initials: M
authors.lastname: Markman